Seeking Alpha
 

CVS Health Corporation (CVS)

- NYSE
  • Sep. 19, 2012, 3:58 PM
    With the stock at an all-time high, CVS Caremark (CVS +0.8%) announces board approval of a new repurchase program for up to $6B worth of the company's shares. (PR)
    | 4 Comments
  • Sep. 12, 2012, 8:19 AM
    The DEA has withdrawn the controlled substance registrations of two CVS Caremark (CVS) pharmacies in Florida after some retail locations experienced sharply higher sales of the addictive prescription painkiller oxycodone. The DEA says CVS and its wholesale suppler Cardinal Health should have realized that the sales increase was a sign that the drugs were be resold in the black market.
    | 1 Comment
  • Sep. 4, 2012, 11:51 AM
    The FTC says checks will soon be in the mail for 13K Medicare beneficiaries who were charged too much by CVS Caremark (CVS -0.1%) at pharmacies. Though the monetary hit is relatively minor for CVS, it's in the middle of trying to hit its forecast of retaining at least 50% of the Walgreen customers who it snapped up during the Express Scripps impasse.
    | Comment!
  • Aug. 28, 2012, 12:30 PM
    A light flu season and increased competition over flu shots hit the bottom lines of drugstore chains last year, so this year they've decided to get an early jump to try to edge out retail players such as Wal-Mart and Target. CVS Caremark (CVS +0.5%), Walgreen (WAG -0.4%), and Rite Aid (RAD -0.5%) have all rolled out promotions aimed at getting customers into their pharmacies before the big boys catch the flu shot sale.
    | 1 Comment
  • Aug. 16, 2012, 9:39 AM
    Cantor Fitzgerald initiates both Walgreen (WAG -0.2%) and CVS Caremark (CVS +0.1%) with Buy ratings. While Walgreen is likely to benefit from the impact of acquisitions and generic drugs, CVS should see margin gains in retail and PBM operations this year, according to analyst Ajay Jain.
    | Comment!
  • Aug. 14, 2012, 6:15 PM
    Bespoke posts tables of sell-side analysts' most loved and most hated S&P 500 stocks. Eight boast at least 90% Buy ratings: SLM, A, SLB, CVS, ATI, COV, FLR, EMC. Take analyst recommendations with a fistful of salt but they're at least a sentiment indicator; note "the most loathed stock of all" - Sears (SHLD) - is up more than 70% YTD.
    | 5 Comments
  • Aug. 14, 2012, 8:25 AM
    The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores.
    | 4 Comments
  • Aug. 8, 2012, 9:25 AM
    Shares of CVS Caremark (CVS) ride a timely upgrade from BMO Capital higher. Analysts cite increased earnings potential and less uncertainty on the impact of the Walgreen-Express Script dispute on results as they raise their rating on the drugstore chain to Outperform from Market Perform. CVS +1.1% premarket.
    | Comment!
  • Aug. 7, 2012, 7:25 AM
    More on CVS Caremark (CVS): Pharmacy Services sales up 28.2% Y/Y to $18.4B, led by new client starts and drug cost inflation. Retail Pharmacy 6.9% higher to $15.8B, with Walgreen-Express Scripts dispute impacting results. Raises and narrows full-year EPS to $3.32-$3.38, up from prior guidance of $3.23-$3.33. (PR)
    | Comment!
  • Aug. 7, 2012, 7:07 AM
    CVS Caremark (CVS): Q2 EPS of $0.81 beats by $0.02. Revenue of $30.7B misses by $270M
    | 5 Comments
  • Aug. 7, 2012, 12:05 AM
    Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE
    | Comment!
  • Aug. 6, 2012, 5:30 PM
    Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE
    | 1 Comment
  • Aug. 3, 2012, 1:00 PM
    CVS Caremark (CVS -0.9%) trades lower after Cleveland Research warns that the number of accounts that it loses back to Walgreen from returning customers may be even more than the 50% it forecast earlier this month. Promotional activity and advertising from Walgreen may be contributing to the extra pharmacy account losses.
    | 1 Comment
  • Jul. 19, 2012, 10:35 AM
    CVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement. The drugstore operator adds $0.05 to its overall FY12 estimate of extra business from the WAG-ESRX dispute after factoring in that it will retain 50% of the customers it gained from Walgreen through Q4.
    | Comment!
  • Jul. 19, 2012, 9:10 AM
    Premarket gainers: MLNX +42%. SCSS +21%. GGC +16%. NOK +13%. WAG +11%. SWKS +10%. TXT +9%. EDU +8%. EBAY +8%. ALU +7%. QCOM +6%. PPG +5%. LUV +5%.
    Losers: ANTH -15%. DCIX -15%. JCI -8%. CVS -6%.
    | Comment!
  • Jul. 19, 2012, 8:17 AM
    Shares of CVS Caremark (CVS) fall off 7.9% premarket after Walgreen and Express Scripts hash out a new pharmacy network agreement. The company had been one of the biggest beneficiaries of the WAG-ESRX dispute.
    | 1 Comment
Visit Seeking Alpha's
CVS vs. ETF Alternatives
Company Description
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Healthcare
Industry: Drug Stores
Country: United States